Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Best duration of dual antiplatelet therapy after drug-eluting stent implantation: an updated network meta-analysis of randomized controlled trials

Published:2019-01-02 Issue:1 Volume:9 Page:9-17
ISSN:2000-9666
Container-title:Journal of Community Hospital Internal Medicine Perspectives
language:en
Short-container-title:Journal of Community Hospital Internal Medicine Perspectives

Author:

Barbarawi Mahmoud¹^ORCID,Kheiri Babikir¹^ORCID,Zayed Yazan¹^ORCID,Aburahma Ahmed¹,Osman Mohammed¹^ORCID,Barbarawi Owais²,Hicks Michael¹,Hassan Mustafa³,Alkotob Mohammad L.³,Bachuwa Ghassan¹

Affiliation:

1. Department of Internal Medicine, Hurley Medical Center/Michigan State University, Flint, MI, USA

2. Department of Internal Medicine, Mutah University, Al-Karak, Jordan

3. Department of Cardiology, Hurley Medical Center/Michigan State University, Flint, MI, USA

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/20009666.2018.1562853

Reference40 articles.

1. Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period